BIWH 3

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

HealthyPeripheral Arterial Disease

Phase 1

Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia

TerminatedNCT02215824

Boehringer IngelheimPeripheral Arterial Disease

Start: 2002-10-31Updated: 2014-08-22

Pharmacokinetics and Pharmacodynamics of BIWH 3 in Healthy Duffy Positive vs. Duffy Negative Male Volunteers

CompletedNCT02249117

Boehringer IngelheimHealthy

Start: 2003-06-30Updated: 2014-09-25